Journal of the American Pharmacists Association

Papers
(The TQCC of Journal of the American Pharmacists Association is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Editorial Board194
Journal of the American Pharmacists Association Reviewers—202169
Advancing pharmacy technician roles in practice: Advancing pharmacy technician roles in addressing social determinants of health68
Effects of home medication review on drug-related problems and health-related quality of life among community-dwelling older adults in China65
Naloxone analogy and opioid overdose terminology preferences among rural caregivers: Differences by race61
Educating the public about toxic chemicals that we unknowingly consume: A potential important role for the practicing pharmacists58
Trust in information sources during the COVID-19 pandemic and its association with vaccine trust among a sample of Hispanic adults46
An endless array of opportunities45
Impact of the COVID-19 pandemic on pharmacists practicing in community pharmacies in the state of Nebraska41
Associated factors to non-medical and medical use of psychoactive medication among Mexican adolescents and adults in a national household survey33
Pharmacists’ answer to the COVID-19 pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 vaccination across sociodemographic characteristics—United States32
Development of a productivity model at a pharmacy consolidated service center29
Consensus-building in the APhA House29
A positive change in student positivity about pharmacy29
Pharmacist perceptions of motivation and well-being using self-determination theory: A qualitative study28
Editorial Board27
Bibliometric analysis of United States and global obstetrical pharmacy literature from 1994 to 202327
“You didn’t have a choice, but to be on your train. The train was moving”: West Virginia pharmacists’ perspectives on opioid dispensing during the evolution of the opioid crisis25
Implementation of a self-measured blood pressure program in a community pharmacy: A pilot study24
OTC hearing aids: An opportunity for collaborative working relationships between pharmacists and audiologists22
Determining essential elements and functionalities for a patient record system in community pharmacy22
Evaluation of pharmacist impact on diabetes outcomes for telehealth and hybrid care delivery versus in-office visits21
Job satisfaction among board-certified pharmacists in Virginia21
Impact of stewardship intervention on antibiotic prescribing prior to dental procedures in a veteran population20
Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit20
Vancomycin-induced elevation of liver enzyme levels in a 3-year-old boy with bacterial meningitis: A pediatric case report20
A retrospective review of the impact of immunization eCare plans in community-based pharmacy setting20
A systematic review with meta-analysis of parental interventions for human papillomavirus vaccine uptake19
Awareness, perceptions, and attitudes toward community pharmacist clinical services: An analysis of data from 2004 and 201819
Innovative partnership in Connecticut to expand health professional eligibility to administer COVID-19 vaccines19
Standardization of medication inventory in an urban family medicine clinic19
Pharmacy deserts: More than where pharmacies are18
Polypharmacy among COVID-19 patients: A systematic review18
Examining Structural Characteristics for Implementing Opioid Use Disorder Services in Community-Based Pharmacies18
Celebrating our peer reviewers and authors!18
“I really had somebody in my corner.” Patient experiences with a pharmacist-led opioid tapering program18
Independent community pharmacists’ attitudes and intentions toward dispensing buprenorphine/naloxone for opioid use disorder17
The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception17
Getting educated on care for the LGBTQ community16
Weight loss differences seen between glucagon-like peptide–1 receptor agonists and sodium–glucose cotransporter–2 inhibitors for treatment of type 2 diabetes16
Table of Contents16
Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine16
Helping patients understand and use medications appropriately16
An analysis of national news coverage of semaglutide for weight loss15
Over-the-counter Pediculus humanus capitis treatment: The nit comb is not appropriate for all hair types!15
Innovate, lead, advocate: How to combat job market saturation15
Pharmacy 2050: A new clinical and patient experience15
2024 Remington Honor Medal Address: Caring for the underserved15
Provision of maternal health services among Ohio community pharmacists practicing in maternity care deserts15
Editorial Board15
Path forward15
Association between medication regimen complexity and glycemic control among patients with type 2 diabetes14
Erratum14
Comparative safety of generic versus brand calcineurin inhibitors in solid organ transplant patients: A systematic review and meta-analysis14
Specialty pharmacy interventions benefit patients receiving HIV postexposure prophylaxis14
Assessing the effects of pharmacist education on colorectal cancer screening and access to a stool-based DNA test13
Older adults’ perceptions of deprescribing chronic benzodiazepines13
Impact of a pharmacist-led, primary medication nonadherence intervention program on prescription fills in underserved patient populations13
Pilot implementation of the PharmNet naloxone program in an independent pharmacy13
An assessment of a sleep aid and sleep promotion practices in hospitalized medical patients12
Access to pharmacies and pharmacy services in New York City, Los Angeles, Chicago, and Houston, 2015-202012
Impact of pharmacist intervention to improve medication access for patients with diabetes12
Pharmacist roles in the Medication Use Process: Qualitative analysis of stakeholder perceptions12
Efficacy and safety of apixaban compared to warfarin for nonvalvular atrial fibrillation in end-stage renal disease on hemodialysis12
Investigating HIV viral suppression rates at varying levels of adherence to antiretroviral therapy within a medical home model12
Identifying racial disparities in the management of heart failure with reduced ejection fraction12
Psychological impact of the COVID-19 outbreak in community pharmacists: A longitudinal study11
Implementation of pharmacist recommendations in patients with type 2 diabetes enrolled in an employer-sponsored health plan11
Developing sustainable workflows for community pharmacy–based SARS-CoV-2 testing11
Implementation of a standardized process for outpatient COVID-19 treatments at a Veterans Affairs medical center11
Associations between the use of a real-time benefit tool and measures related to prescription obtainment found in order type subgroups11
Eosinophilic pustular folliculitis due to naltrexone: A case report11
Association of pharmacist intervention counseling with medication adherence and quality of life: A systematic review and meta-analysis of randomized trials11
The relationship between pharmacist emotional intelligence, occupational stress, job performance, and psychological affective well-being11
A systematic review of the treatment of active anogenital warts with human papillomavirus vaccines11
Pharmacist leaders in public and global health: Nurturing practitioners at the forefront of an ever-connected world11
Specialty pharmacy integration and the role of an advanced certified pharmacy technician in prescription cannabidiol access11
Community pharmacist perceptions of increased technician responsibility11
We all have a role to play in suicide prevention11
Pharmacist furnishing of naloxone in California: A follow-up analysis11
Editorial Board10
Identifying the educational needs of pharmacists engaging in professional development: A global systematic review10
COVID-19 pandemic vaccination preparedness strategies for independent community pharmacies10
Clinical impact of a community pharmacy-based health and wellness introductory pharmacy practice experience10
Evaluation of a community-based pharmacy resident-led continuous glucose monitoring program within a family medicine clinic10
Acyclovir dosing in herpes encephalitis: A scoping review10
Concomitant use of levothyroxine and interacting medications in U.S. ambulatory care visits10
Effects of instructional video and community radio broadcasting interventions to improve knowledge and behavior of antibiotic use in the COVID-19 era10
Characterizing acute and postsurgical pain management in patients receiving buprenorphine or buprenorphine/naloxone10
Achievement of serum uric acid target by rheumatology clinic pharmacists compared with primary care providers in patients with gout10
BreatheOut: Development and implementation of a pharmacist-led, culturally tailored smoking cessation program for transgender and gender diverse patients10
How community pharmacists envision using pharmacogenomic data: A qualitative analysis10
Four-factor prothrombin complex concentrate versus andexanet alfa for direct oral anticoagulant reversal10
Informing collaborative relationships between community pharmacists and health care professionals in primary care practices10
Serving underserved Hispanic populations: Practical strategies for pharmacy professionals9
The addition of women’s health initiatives to an established remote population health introductory pharmacy practice experience9
Vitreous hemorrhage during GLP-1 receptor agonist treatment9
Empowering and educating the next generation of pharmacists through children’s books: A quality assurance initiative9
Impact of health information exchange access on medication management recommendations in a community-based pharmacy setting9
Reprint of Implementation of a pharmacist-led ARVSP in an academic hospital to reduce ART errors9
Impact of a pharmacy-driven culture callback protocol on antimicrobial therapy optimization in the emergency department9
Feasibility of reaching populations at high risk for HIV in community pharmacies9
Prevalence of medically unsupervised activated charcoal use a cause for concern in celiac disease?9
Implementation of a pharmacist-led diabetes management service in an endocrinology clinic9
Clinician burnout during the COVID-19 pandemic before vaccine administration9
Amplifying our voice9
Table of Contents9
Implementation of an older adult epilepsy clinic utilizing pharmacist services9
Development and validation of patient-community pharmacist encounter toolkit regarding substance misuse: Delphi procedure8
Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A missed opportunity for pharmacist 8
Concordance between reported medication taking behavior and prescription instructions for patients with chronic obstructive pulmonary disease visiting community pharmacies8
Impact of pharmacist motivational interviewing on hepatitis B vaccination in adults with diabetes8
Comparison of the properties of the English and Spanish versions of the Patient Satisfaction with Pharmacist Services Questionnaire 2.08
Meeting the needs of rural veterans through rapid implementation of pharmacist-provided telehealth management of diabetes during the COVID-19 pandemic8
Call to expand access to vaccines for children through pharmacist education, collaboration, and advocacy8
Evaluation of temperature excursions from USP <659> recommendations during mail transit8
Implementation of a clinical pharmacist-driven comprehensive medication management program in an outpatient wound healing center8
Effectiveness of prescribing codes in reducing inappropriate proton pump inhibitors in ambulatory care8
Pharmacist-provider collaborative visits after hospital discharge in a comprehensive acute kidney injury survivor model8
A 2023 Washington State pharmacist workforce survey: Employment and patient care roles8
Improving health equity: Evaluation of accessible written medication information for patients with visual impairment8
Over-the-counter and under the radar: Improving safety and effectiveness of nonprescription analgesics8
Patient experiences with pharmacist prescribed hormonal contraception in California independent and chain pharmacies8
Impact of a resident-driven wellbeing committee on resident-perceived wellbeing, burnout, and resilience8
After the Storm: Reflections on Interprofessional Collaboration after Hurricane Helene in Western North Carolina8
Reprint of: Impact of a pharmacist-led weight management service in a cardiology clinic8
Evaluation of quality measure attainment with pharmacist-delivered Medicare annual wellness visits8
A call to action: Maximizing the pharmacy technician role through certifications8
Home versus outpatient hospital intravenous immunoglobulin infusion and health care resource utilization8
Human versus machine editing of electronic prescription directions8
APhA Awards & Fellow Recipients8
Readiness of community pharmacies to implement an opioid safety intervention8
Remington Honor Medal Address: Lessons learned from the road less traveled8
Chain community pharmacists’ requests for patient information during routine care8
Institutional policy consideration for medical cannabis8
Dare 2 Discuss social media campaign: An educational initiative to improve opioid use disorder discussions between the pharmacist and patient8
Impact of star ratings on Medicare health plan enrollment: A systematic literature review8
Characteristics and health service use of Medicaid-insured individuals filling naloxone under a standing order in Louisiana8
A systematic review of apixaban in prevention and treatment of cancer-associated venous thromboembolism8
2023 Remington Medal Address: Achieving social and professional autonomy in pharmacy8
Table of Contents7
The potential feasibility of tobacco-focused medication therapy management in pharmacies affiliated with Federally Qualified Health Centers: Perspectives of pharmacists7
Evaluation of a pharmacy technician-based medication prior authorization program7
Pharmacists can be DEAI change agents7
Megestrol acetate as an overlooked cause of hyperglycemia in end-stage renal disease: A case of polypharmacy7
Sociodemographic inequities in COVID-19 vaccination among adults in the United States, 20227
Mental health in rural agricultural workers: The role of a community pharmacist7
Complexity of patient encounters within a clinically integrated community pharmacy network Medicaid payer program7
Characteristics, knowledge, attitude, and practice of pharmacy personnel in supporting tuberculosis treatment: A multicenter cross-sectional study in a high-burden tuberculosis country7
You are heroes7
Faceless teammates: Digital communication’s impact on interprofessional collaboration7
Outcomes of a college-led community-based influenza vaccine program for underserved New York City communities7
Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous glucagon-like peptide-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine case report7
Impact of pharmacist prescribing through direct pharmacy access policies on access to hormonal contraception7
Revisiting the continuum of pharmacist prescriptive authority7
An analysis of the impact of a multimodal therapy order set on postoperative opioid prescribing after orthopedic shoulder procedures7
Preparedness for a pandemic: Independent community pharmacists’ experiences delivering COVID-19 vaccines7
Impact of a Yin Yoga and meditation intervention on pharmacy faculty and student well-being7
Retraining transplant pharmacy staff to reduce Medicare Part B prescription billing errors post-transplant7
Passion and purpose drive the 2022 APhA House of Delegates sessions7
Pharmacist-led, checklist intervention did not improve adherence in ambulatory patients starting/resuming DOACs7
CORRECTION7
Glycemic relapse in a collaborative primary care-based type 2 diabetes management program7
The pharmacists behind the front lines: One year later7
Bringing providers into the community pharmacy: Experiential education7
Unleashing the power of science and research to advance pharmacy6
Implementation of a North Dakota opioid misuse and overdose prevention program in West Virginia6
Assessing barriers to COVID-19 diagnostic testing in community pharmacies: Insights from Alabama6
The availability of fentanyl test strips in Georgia community pharmacies6
Pharmacy work: Intrinsic motivation and extrinsic rewards across role and setting6
Systematic review of oral pharmacotherapeutic options for the management of uterine fibroids6
Factors that influence how adults select oral over-the-counter analgesics: A systematic review6
Patient perceptions of acute infectious disease point-of-care tests and treatment within community pharmacy settings6
The implications of data aggregation on propagating racial and ethnic disparities within the health care landscape: Actionable recommendations and considerations for pharmacists6
Impact of outpatient pharmacist dispensing in an opioid use disorder clinic6
Virtual town halls addressing vaccine hesitancy among racial and ethnic minorities: Preliminary findings6
2022 Pharmacy Quality Alliance (PQA) Annual Meeting, May 3-5, 2022, Baltimore, MD6
Improved asthma outcomes among at-risk children in a pharmacist-led, interdisciplinary school-based health clinic: A pilot study of the CAReS program6
Empowering pharmacy’s future: Showcasing resident research6
Why can’t we be friends? The manufactured fear of pharmacist “scope creep”6
Utilization of an implementation framework to obtain provider perspectives of pharmacist-led clinical services6
Self-health care behaviors and knowledge of youth living with HIV6
A false positive fentanyl result on urine drug screen in a patient treated with ziprasidone6
Clinician attitudes toward referring patients to pharmacists for tobacco cessation services6
The community pharmacist as an independent prescriber: A scoping review6
Exploring perspectives on vaccinations delivered in complementary nonclinical settings and by nonphysician health professionals: A qualitative interview study6
Pharmacist biosimilar survey reveals knowledge gaps6
Implementing a telemedicine-led heart failure medication regimen optimization clinic in medically underserved heart failure populations6
Peer reviewers and authors: Thank you!6
Reprint of: Impact of a pharmacist-driven COPD clinic on outcomes related to COPD in a federally qualified health center6
Evaluation of an opioid pain teleconsultation service to address the opioid overdose epidemic in Colorado: A Health First Colorado demonstration project6
Slowed progression: The utility of Test to Treat initiatives in improving the neglected inequities of COVID-19 among racially/ethnically minoritized groups6
“You’re on mute”—lessons learned with virtual academic detailing6
Cost-related nonadherence can be explained by a general nonadherence framework6
Practical strategies for ensuring safety of medication overrides from automated dispensing cabinets6
Enhancing availability of services to control hypertension through a team-based care approach that includes pharmacists6
Assessment and categorization of medication errors in a veterinary teaching hospital6
A successful intervention to improve medication adherence in Black patients with hypertension: Mediation analysis of 28-site TEAM trial6
Table of Contents5
Outside front cover5
Patients’ willingness to pay for naloxone: A national cross-sectional survey of prescription opioid users with chronic pain in the United States5
Knowledge about COVID-19 vaccine and vaccination in Vietnam: A population survey5
Innovating the Model for Student Pharmacists to Increase Access to Hepatitis C Testing (Project IMPACT)5
Improving and validating a rating scale to assess student pharmacists’ perception of professional identity5
Socialized and traumatized: Pharmacists, underserved patients, and the COVID-19 vaccine5
IDS pharmacists: Bridging the translational research gap for pharmacy practice5
Glucagon-like peptide-1 receptor agonists use for type 2 diabetes mellitus in end-stage renal disease5
The impact of California wildfires on patient access to prescription opioids5
Perceptions of COVID-19 vaccines in a predominantly Hispanic patient population from the Texas–Mexico border5
Implementation of a specialty pharmacy in an ambulatory care setting in Saudi Arabia: Patient experience and operational outcomes5
Optimizing electronic health record efficiency5
Expanded roles of community pharmacists in COVID-19: A scoping literature review5
Emerging stronger than ever in 2021-20225
Impact of pharmacist counseling to enhance the accessibility of naloxone nasal spray to patients in a community pharmacy setting5
Outside front cover5
Determinants of COVID-19 vaccine hesitancy among pregnant persons5
Evaluation of cure rate in patients with hepatitis C virus completing shortened courses of treatment5
Comparison of dosing errors between tenecteplase and alteplase for management of acute ischemic stroke5
Diabetes outcomes before and during telehealth advancements surrounding COVID-195
Implementing a chatbot on Facebook to reach and collect data from thousands of health care providers: PharmindBot as a case5
Identifying barriers to utilization of a medication access program among referred patients surveyed after discharge from an acute care hospital5
Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event5
Evaluation of tricyclic antidepressant deprescribing in the treatment of diabetic peripheral neuropathy within federally qualified health centers5
Analyzing override patterns in profiled automated dispensing cabinets at a tertiary care hospital in Saudi Arabia5
Table of Contents5
A call to action: Now is the time to address systemic racism5
Gabapentin controlled substance status5
Community pharmacists’ provision of sexual and reproductive health services: A cross-sectional study in Alberta, Canada5
Table of Contents5
Examining the case for direct contracting: A multistakeholder case study5
Changes in Arkansans’ attitudes toward pharmacist involvement and regulation of medical cannabis following its availability in Arkansas5
Effects of progesterone on gender affirmation outcomes as part of feminizing hormone therapy5
Evaluating trends in pharmacist e-prescribing: 2019–20225
Defining my worth5
Access to on-campus contraception on college and university campuses in North Carolina5
Preparing community pharmacy teams for health information exchange (HIE)5
A mom pharmacist working during the pandemic5
The impact of pain management changes to an inpatient general admission electronic order-set5
Collaborative drug therapy modification (CDTM): Facilitators, barriers, and perceptions of individual pharmacist participation in Georgia5
Impact of a pharmacist-led mood stabilizer laboratory monitoring protocol5
Table of Contents5
A qualitative exploration of unintentional versus intentional exposure to fentanyl among people who use drugs in Austin, TX5
Exploring the frontline experiences of pharmacy technicians during the opioid epidemic in community pharmacies5
Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: A systematic review and network meta-analysis5
The role of pharmacy in promoting public health: Pharmacy and public health in 20504
2024 Pharmacy Quality Alliance (PQA) Annual Meeting, May 14-16, 2024, Baltimore, MD4
Battling professional self-sabotage: Embracing standard of care as the future of pharmacy regulation4
Challenges to decarbonizing medication prescribing and use practices: A call to action4
Reimagining the ambulatory care training pathway4
Naloxone access in perinatal substance use disorder4
0.15452098846436